BCR/ABL1 Qualitative Detection by Real-time RT-PCR*
฿2,600.00
Detects whether a BCR/ABL1 fusion transcript is present using real-time reverse-transcription PCR but does not quantify its level.
Typical Use
Used during the initial investigation of suspected BCR/ABL1-positive blood cancers, particularly chronic myeloid leukaemia and some forms of acute lymphoblastic leukaemia. Quantitative testing is required for routine treatment monitoring.
Preparation
CBC results required